An ISO 9001:2015 Certified Firm

Pharmaceutical & Life Sciences

Preparation process for Protease Inhibitor Intermediates

Invention relates to Preparation Process of racemic 6, 6-dimethyl-3-azabicyclo-[3.1.0]-hexane, a key raw material for the preparation of key intermediate (1R, 2S, 5S) - methyl 6,6-dimethyl -3-azabicyclo [3.1.0] hexane-2 carboxylic acid for the class of inhibitors of Protease such as Boceprevir. The process is efficient and economic as in this preparation process lithium aluminium hydride is not used.
Status of Patent and more about technology: Click here

Novel Terpenoidal Based Analogue of Vasicine with Multiple Therapeutic Activities


Invention relates to the novel compound of formula I and pharmaceutically acceptable salts thereof and use of the said novel compound for the treatment of asthma. The invention involves design, synthesis and biological evaluation of a novel terpenoid based compound and pharmaceutical acceptable salts thereof which possess multiple therapeutic effects like bronchodilatory, anti- allergic and anti-tussive effects.
Status of Patent and more about technology: Click here

Broad Spectrum Antiviral Polysaccharide_Microbial Technology


Technology relates to a Broad-Spectrum Antiviral Polysaccharides from the marine, heterotrophic, microalgae called thraustochytrids, these microalgae also produce the omega-3 fatty acid, DHA. Therefore, this is an economical process to produce two valuable compounds from safe microorganisms. Proposed Technology addresses following Viruses: Enterovirus, Retrovirus, Cytomegalovirus, Adenovirus, Herpes simplex virus.
Status of Patent and more about technology: Click here